Therapeutic plasma exchange in multiple sclerosis patients with an aggressive relapse: an observational analysis in a high-volume center

An evidence-based treatment for a Multiple Sclerosis (MS) relapse is an intravenous administration of 3–5 g of Methylprednisolone. In case of insufficient effect or corticosteroids intolerance, the therapeutic plasma exchange (TPE) is indicated. To assess the clinical effect of TPE in treatment of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunganic, R., Blahutova, S., Revendova, K., Zapletalova, O., Hradilek, P., Hrdlickova, R., Ganesh, A., Cermakova, Z., Bar, M., Volny, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626567/
https://www.ncbi.nlm.nih.gov/pubmed/36319704
http://dx.doi.org/10.1038/s41598-022-23356-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626567/
https://www.ncbi.nlm.nih.gov/pubmed/36319704
http://dx.doi.org/10.1038/s41598-022-23356-w

Ejemplares similares